Modeling miRNA-mRNA interactions that cause phenotypic abnormality in breast cancer patients
- PMID: 28793339
- PMCID: PMC5549916
- DOI: 10.1371/journal.pone.0182666
Modeling miRNA-mRNA interactions that cause phenotypic abnormality in breast cancer patients
Abstract
Background: The dysregulation of microRNAs (miRNAs) alters expression level of pro-oncogenic or tumor suppressive mRNAs in breast cancer, and in the long run, causes multiple biological abnormalities. Identification of such interactions of miRNA-mRNA requires integrative analysis of miRNA-mRNA expression profile data. However, current approaches have limitations to consider the regulatory relationship between miRNAs and mRNAs and to implicate the relationship with phenotypic abnormality and cancer pathogenesis.
Methodology/findings: We modeled causal relationships between genomic expression and clinical data using a Bayesian Network (BN), with the goal of discovering miRNA-mRNA interactions that are associated with cancer pathogenesis. The Multiple Beam Search (MBS) algorithm learned interactions from data and discovered that hsa-miR-21, hsa-miR-10b, hsa-miR-448, and hsa-miR-96 interact with oncogenes, such as, CCND2, ESR1, MET, NOTCH1, TGFBR2 and TGFB1 that promote tumor metastasis, invasion, and cell proliferation. We also calculated Bayesian network posterior probability (BNPP) for the models discovered by the MBS algorithm to validate true models with high likelihood.
Conclusion/significance: The MBS algorithm successfully learned miRNA and mRNA expression profile data using a BN, and identified miRNA-mRNA interactions that probabilistically affect breast cancer pathogenesis. The MBS algorithm is a potentially useful tool for identifying interacting gene pairs implicated by the deregulation of expression.
Conflict of interest statement
Figures
Similar articles
-
Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.Cell Biochem Biophys. 2014 Dec;70(3):1849-58. doi: 10.1007/s12013-014-0142-y. Cell Biochem Biophys. 2014. PMID: 25087086
-
Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.J Cell Mol Med. 2015 Dec;19(12):2874-87. doi: 10.1111/jcmm.12681. Epub 2015 Sep 28. J Cell Mol Med. 2015. PMID: 26416600 Free PMC article.
-
Model based on GA and DNN for prediction of mRNA-Smad7 expression regulated by miRNAs in breast cancer.Theor Biol Med Model. 2018 Dec 29;15(1):24. doi: 10.1186/s12976-018-0095-8. Theor Biol Med Model. 2018. PMID: 30594253 Free PMC article.
-
Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.Anticancer Res. 2017 Aug;37(8):4455-4468. doi: 10.21873/anticanres.11841. Anticancer Res. 2017. PMID: 28739740
-
DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.Gene. 2017 Mar 10;604:1-8. doi: 10.1016/j.gene.2016.12.018. Epub 2016 Dec 18. Gene. 2017. PMID: 27998789
Cited by
-
Metastasis-associated lung adenocarcinoma transcript 1 molecular mechanisms in gastric cancer progression.World J Gastrointest Oncol. 2023 Sep 15;15(9):1520-1530. doi: 10.4251/wjgo.v15.i9.1520. World J Gastrointest Oncol. 2023. PMID: 37746646 Free PMC article. Review.
-
Evaluation of the Relative Frequency of Epstein-Barr Virus Infection in Patients with Recurrent Breast Cancer Compared with Patients with Nonrecurrent Breast Cancer.Adv Biomed Res. 2023 Feb 25;12:34. doi: 10.4103/abr.abr_381_21. eCollection 2023. Adv Biomed Res. 2023. PMID: 37057233 Free PMC article.
-
Imaging genetic association analysis of triple-negative breast cancer based on the integration of prior sample information.Front Genet. 2023 Feb 22;14:1090847. doi: 10.3389/fgene.2023.1090847. eCollection 2023. Front Genet. 2023. PMID: 36911413 Free PMC article.
-
Expression of Selected miRNAs in Normal and Cancer-Associated Fibroblasts and in BxPc3 and MIA PaCa-2 Cell Lines of Pancreatic Ductal Adenocarcinoma.Int J Mol Sci. 2023 Feb 10;24(4):3617. doi: 10.3390/ijms24043617. Int J Mol Sci. 2023. PMID: 36835029 Free PMC article.
-
Deep Learning and Machine Learning with Grid Search to Predict Later Occurrence of Breast Cancer Metastasis Using Clinical Data.J Clin Med. 2022 Sep 29;11(19):5772. doi: 10.3390/jcm11195772. J Clin Med. 2022. PMID: 36233640 Free PMC article.
References
-
- Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell. 2012;149(3):515–24. doi: 10.1016/j.cell.2012.04.005 - DOI - PMC - PubMed
-
- Yan L-X, Huang X-F, Shao Q, Huang M-Y, Deng L, Wu Q-L, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. Rna. 2008;14(11):2348–60. doi: 10.1261/rna.1034808 - DOI - PMC - PubMed
-
- Schwarzenbacher D, Balic M, Pichler M. The role of microRNAs in breast cancer stem cells. International journal of molecular sciences. 2013;14(7):14712–23. doi: 10.3390/ijms140714712 - DOI - PMC - PubMed
-
- Calin GA, Croce CM. MicroRNA signatures in human cancers. Nature Reviews Cancer. 2006;6(11):857–66. doi: 10.1038/nrc1997 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
